Evidence map›Paper›PMID 42821620›Full record

ArticlePLoS neglected tropical diseases2026

Microfilaremic loiasis is associated with T cell hyporesponsiveness against SARS-CoV-2.

Maximilian Augé Stock, Dearie Glory Okwu, Ayong More, Anna Doralt, Rodrigue Bikangui, Ismaël Pierrick Mikelet Boussoukou, Kirsten Alexandra Eberhardt, Maren Sandkuhl, Rella Zoleko Manego, Ghyslain Mombo-Ngoma and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Maximilian Augé StockCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Dearie Glory OkwuCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Ayong MoreCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Anna DoraltCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Rodrigue BikanguiCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Ismaël Pierrick Mikelet BoussoukouCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Kirsten Alexandra EberhardtDepartment of Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Maren SandkuhlI, Department of Medicine, Division of Infectious Diseases, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Rella Zoleko ManegoCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Ghyslain Mombo-NgomaCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Matthew McCallCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Minka BreloerSection Interface, Helminth Immunology Group, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Meral EsenCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Marylyn AddoI, Department of Medicine, Division of Infectious Diseases, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Bertrand LellCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Luzia VeletzkyCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Rafiou AdamouCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Maria Sophia MackrothI, Department of Medicine, Division of Infectious Diseases, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.ORCID https://orcid.org/0000-0001-5178-8297

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLoiasis is a chronic filarial infection endemic to Central and West Africa. Although long considered benign, increasing evidence links loiasis to substantial morbidity and mortality. The infection is associated with immune modulation, including Th2-skewed responses and elevated regulatory cytokines. Clinically, loiasis is classified as microfilaremic (presence of circulating microfilariae) or amicrofilaremic ("occult") disease, the latter defined by a history of eyeworm migration without detectable microfilaremia. This study investigated how chronic L. loa infection influences antibody and T cell responses to SARS-CoV-2 following natural infection.

methodsBetween 2022 and 2024, this cross-sectional study was done in rural and periurban villages of the Ngounié and Moyen-Ogooué provinces of Gabon. Study procedures included diagnostics for loiasis and immunological assays. Microfilaremia was confirmed by stained blood smear microscopy, and occult disease was identified using the Rapid Assessment Procedure for Loiasis. SARS-CoV-2-specific IgG responses to spike and nucleocapsid proteins were measured by ELISA, and IFN-γ responses to spike antigen were assessed using an interferon-gamma release assay.

resultsOverall, 192 participants were categorized as microfilaremic (n = 43), occult loiasis (n = 59), or without evidence of active loiasis (n = 90). IFN-γ responses were reduced in microfilaremic individuals compared with other participants (p = 0.031), whereas IgG responses did not differ. Subsequent analysis across the three groups confirmed that IFN-γ responses were lower in microfilaremic compared with occult participants (p = 0.012).

conclusionThese findings suggest that microfilaremic loiasis may impair proinflammatory T cell responses to viral antigens, highlighting the need for further research into the broader immunological effects of Loa loa infection in endemic populations.

Indexed as

COVID-19LoiasisSARS-CoV-2T-LymphocytesAdolescentAdultAnimalsAntibodies, ViralCross-Sectional StudiesFemaleGabonHumansImmunoglobulin GInterferon-gammaLoaMaleAntibodies, ViralImmunoglobulin GInterferon-gamma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.